Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling
Extrapolation of pharmacokinetic (PK) parameters from in vitro or in vivo animal to human is one of the main tasks in the drug development process. Translational approaches provide evidence for go or no-go decision-making during drug discovery and the development process, and the prediction of human...
Main Authors: | Go-Wun Choi, Yong-Bok Lee, Hea-Young Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/4/168 |
Similar Items
-
Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP)
by: Suein Choi, et al.
Published: (2019-07-01) -
Bridging pharmacokinetics between herbivorous mammal species by allometric analysis: A case study of ceftiofur
by: Haritova Aneliya, et al.
Published: (2012-01-01) -
Prediction of Deoxypodophyllotoxin Disposition in Mouse, Rat, Monkey and Dog by Physiologically-based Pharmacokinetic Model and the Extrapolation to Human
by: Yang Chen, et al.
Published: (2016-12-01) -
A Computational Workflow for Probabilistic Quantitative in Vitro to in Vivo Extrapolation
by: Kevin McNally, et al.
Published: (2018-05-01) -
Tylosin Dosage Adjustment Based on Allometric Scaling in Male Turkeys
by: Błażej Poźniak, et al.
Published: (2021-08-01)